Diffusely increased bone marrow FDG uptake

Last revised by Bahman Rasuli on 15 Jan 2020

Citation, DOI, disclosures and article data

Citation:

Salam H, Rasuli B, Bell D, et al. Diffusely increased bone marrow FDG uptake. Reference article, Radiopaedia.org (Accessed on 20 Apr 2024) https://doi.org/10.53347/rID-12829

DOI:

https://doi.org/10.53347/rID-12829

Permalink:

https://radiopaedia.org/articles/12829?iframe=true

rID:

12829

Article created:

15 Jan 2011, Hani Makky Al Salam

Disclosures:

At the time the article was created Hani Makky Al Salam had no recorded disclosures.

View Hani Makky Al Salam's current disclosures

Last revised:

15 Jan 2020, Bahman Rasuli ◉

Disclosures:

At the time the article was last revised Bahman Rasuli had no recorded disclosures.

View Bahman Rasuli's current disclosures

Revisions:

5 times, by 5 contributors - see full revision history and disclosures

Systems:

Musculoskeletal, Oncology, Spine

Sections:

Gamuts

Tags:

stub, refs, oncology

Synonyms:

Causes of diffusely increased bone marrow FDG uptake
Differential diagnosis of diffusely increased bone marrow FDG uptake
Diffusely increased FDG uptake in bone marrow

A diffuse homogeneous bone marrow FDG uptake usually reflects hyperplastic bone marrow which can be seen in the following conditions:

therapy-related
- granulocyte colony-stimulating factor (G-CSF)
- post-chemotherapy
- erythropoietin
pathological process
- myelodysplastic syndromes
- beta-thalassemia
- chronic myeloid leukemia (CML)
- interleukins in pyrexic states
- cytokines in tumors
- diffuse marrow metastases (less likely)
- severe anemia (hyperplastic marrow)

References

Incoming Links

Promoted articles (advertising)

ADVERTISEMENT: Supporters see fewer/no ads